Eyal Breitbart

This inventor holds 29 USPTO granted patents and 28 published patent applications, plus 7 CIPO patents and 18 EPO patents, primarily in Cancer Therapy. Top assignees: Vascular Biogenics Ltd., Immunewalk Therapeutics, Inc., Vascular Biogenetics Ltd.. Active years: 2009-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Eyal Breitbart. Retrieved from https://idiyas.com/inventor/eyal-breitbart

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 29 (Patent Applications = 28)

% Patents Active = 34.5

CIPO Patents = 7 (Patent Applications = 7)

EPO Patents = 18 (Patent Applications = 33)

Average Co-Inventor Count = 4.0

ph-index = 8

Forward Citations = 158(Granted Patents)

Location History:

Hashmoniam, IL (2015)
Hasmonaim, IL (2016)
Hashmonaim, IL (2009 - 2024)

Company Filing History:

26 out of 46

Vascular Biogenics Ltd.

patents

2 out of 2

Immunewalk Therapeutics, Inc.

patents

1 out of 1

Vascular Biogenetics Ltd.

patent

Years Active: 2009-2024

Loading Chart...

Areas of Expertise:

Anti-Angiogenic Agents

Oxidized Lipids

Glioblastoma

Polynucleotide Constructs

Endothelial Cell Specificity

Adenovirus

FAS-Chimera

Cancer Treatment

Inflammation

Targeted Downregulation

Promoters

Fibrosis

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12109264 - Motile sperm domain containing protein 2 and inflammation (2024-10-08),

2. 11945875 - Motile sperm domain containing protein 2 and cancer (2024-04-02),

3. 11697682 - Motile sperm domain containing protein 2 antibodies and methods of use thereof (2023-07-11),

4. 11311583 - Treatment methods using adenovirus (2022-04-26),

5. 11191848 - Methods of inducing responsiveness to anti-angiogenic agent (2021-12-07),

6. 10464957 - Oxidized lipids and methods of use thereof (2019-11-05),

7. 10383954 - Methods of inducing responsiveness to anti-angiogenic agent (2019-08-20),

8. 10369196 - Compositions and methods for treating glioblastoma GBM (2019-08-06),

9. 10206936 - Oxidized lipids and treatment or prevention of fibrosis (2019-02-19),

10. 10022388 - Oxidized lipids and treatment or prevention of fibrosis (2018-07-17),

11. 9771385 - Oxidized lipids (2017-09-26),

12. 9682154 - Methods of inducing responsiveness to anti-angiogenic agent (2017-06-20),

13. 9567605 - Methods for use of a specific anti-angiogenic adenoviral agent (2017-02-14),

14. 9403887 - Endothelial cell-specific polynucleotides and use thereof (2016-08-02),

15. 9206206 - Oxidized lipid compounds and uses thereof (2015-12-08),

Title: Inventor Eyal Breitbart: Pioneering Innovations in Hashmonaim

Introduction: Eyal Breitbart is a visionary inventor hailing from Hashmonaim, Israel, known for his groundbreaking contributions to various technological fields.

Latest Patents: Eyal Breitbart holds several patents in the areas of renewable energy, artificial intelligence, and medical devices, showcasing his diverse range of expertise and innovation.

Career Highlights: Throughout his illustrious career, Eyal Breitbart has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized industries and improved the lives of many.

Collaborations: Eyal Breitbart has collaborated with top engineers, scientists, and researchers globally, fostering a culture of innovation and excellence in all his projects.

Conclusion: Eyal Breitbart's relentless pursuit of innovation and his passion for creating impactful solutions have solidified his position as a respected inventor in Hashmonaim and beyond.

Profile summary based on public USPTO records.